February 7, 2020
Couetoux du Tertre et al. Clin Proteom 2020;17:5.
Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibition
You might also be interested by
Webcasts & Webinars
Precision Oncology Approaches: Using Proteomics to Build Next-Gen Diagnostic Solutions
May 2, 2023
Proteomics/Mass Spectrometry
More infoBrochures & Infographics
Empower Cancer Research with Proteomics
April 11, 2023
Proteomics/Mass Spectrometry
More info